NCT05878210View on ClinicalTrials.gov

Evaluating the SUBLOCADE Treatment Exit Strategy

CompletedOBSERVATIONAL

Enrollment

12

Participants

Timeline

Start Date

November 24, 2023

Primary Completion Date

May 9, 2025

Study Completion Date

May 9, 2025

Conditions

Opioid Use Disorder

Trial Locations (2)

04102

Comprehensive Addiction Medicine, Portland

T6E6T9

Savera Medical Centre, Edmonton

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Indivior Inc.

INDUSTRY

NCT05878210 - Evaluating the SUBLOCADE Treatment Exit Strategy | Biotech Hunter | Biotech Hunter